This article is more than 5 years old. Information may no longer be current.
Vitiligo, psoriasis studies top dermatology reads for week
Study findings that patients with facial vitiligo experienced significant repigmentation after treatment with topical ruxolitinib 1.5% cream was among the top read articles of the past week on Healio.com/Dermatology.
Other widely-read articles included findings that Xeljanz improved nail psoriasis through 1 year and that long-duration phototherapy for vitiligo enhanced treatment response:
Topical ruxolitinib provides repigmentation in patients with facial vitiligo
Patients with facial vitiligo experienced significant repigmentation after treatment with topical ruxolitinib 1.5% cream, according to recently published study results.
The researchers conducted a 20-week, open-label, proof-of-concept study at Tufts Medical Center in Boston of 11 patients (54.5% men; mean age, 52 years) with a minimum of 1% affected body surface are of vitiligo. Read more
Vitiligo associated with autoimmune thyroid diseases, thyroid cancer
Autoimmune thyroid diseases and thyroid cancer were significantly associated with vitiligo, according to research published in the Journal of the American Academy of Dermatology.
Researchers used the Korean National Health Insurance claims data to study the association between vitiligo and overt autoimmune thyroid diseases and thyroid cancer. Read more
Xeljanz improves nail psoriasis through 1 year
Patients with nail psoriasis who were treated with Xeljanz experienced improvement at week 16, compared with placebo, and improvements maintained through week 52, according to study results recently published in the Journal of the American Academy of Dermatology.
Joseph F. Merola, MD, MMSc, of Brigham and Women’s Hospital and Harvard Medical School, and colleagues conducted a post-hoc analysis of pooled data from two 52-week, randomized double-blind phase 3 studies of 1,859 adults with moderate-to-severe plaque psoriasis. Read more
National Psoriasis Foundation recognizes OTC botanical treatment
The National Psoriasis Foundation has given its seal of recognition to MetaDerm Heal & Prevent cream, an over-the-counter therapeutic botanical treatment for psoriasis, according to a press release from Haus Bioceuticals.
The recognition highlights over-the-counter (OTC) products that are proven safe and effective in the management of psoriasis symptoms, according to the release. Read more
Long-duration phototherapy for vitiligo enhances treatment response
Long-duration phototherapy should be encouraged to enhance vitiligo treatment response, with the most effective response expected on the face and neck, according to a recent review and meta-analysis published in JAMA Dermatology.
Researchers in South Korea conducted a comprehensive database search of Medline, Embase and the Cochrane Library from inception to Jan. 26, 2016. Read more